HMVV

HMVV interprets somatic variants from next-generation sequencing (NGS) data to support cancer genomic analysis and clinical decision-making.

Key Features:

• Iterative development and versioning: Five sequential updates over more than 1.5 years produced version 3 and incorporated end-user feedback.
• Improved computational performance: Enhancements yielded up to an eightfold reduction in bioinformatics pipeline computation time for HMVV’s longest-running assays.
• Reduction of manual errors: Workflow and automation changes minimize opportunities for manual data-entry errors during variant interpretation.
• Workflow integration: Supports pipeline monitoring, variant interpretation, annotation, and integration with laboratory information systems.
• System maintenance, security, and modularity: Includes enhanced defect reporting, heightened data security measures, and increased modularity in code and system environments.
• Validation according to expert guidelines: Each update was validated following expert guidelines to ensure accuracy and performance for clinical applications.

Scientific Applications:

• Cancer somatic variant interpretation: Applied in cancer research laboratories to interpret somatic variants identified by NGS.
• Clinical workflow acceleration: Accelerates interpretation so molecular pathologists can analyze assay results at least two days sooner, supporting timely clinical decision-making.

Methodology:

The associated bioinformatics pipeline is available at https://github.com/hmvv/ngs_pipelines and uses the MAIN_runPipelines.sh script, which is commonly scheduled via a cron job for continuous automated processing.